一、证券市场回顾 南财金融终端数据显示，上周（5月6日-5月9日,下同），上证综指周内上涨1.92%，收于3342.0点，最高3359.73点；深证成指周内上涨2.29%，收于10126.83 点，最高10248.98点；创业板指周内上涨3.27%，收于2011.77点，最高2036.1点。在全球市场中，主要指数有涨有跌。纳斯达克综指下跌0.27%，道琼斯工业 指数下跌0.16%，标普500下跌0.47%。亚太地区，恒生指数上涨1.61%，日经225指数上涨1.83%。 二、新股申购情况 上周有3只新股发行,详情见下表： | 股票代码 | 股票简称 | 申购日期 | | --- | --- | --- | | 301595.SZ | 太力科技 | 20250508 | | 603014.SH | 威高血净 | 20250508 | | 688755.SH | 汉邦科技 | 20250507 | 三、融资融券情况 上周共有16条开始执行回购公告，其中执行金额最多的5条公告为： | 证券代码 | 证券简称 | | --- | --- | | 601877 | 正泰电器 | | 002145 | 中核钛白 | | ...

Group 1: New Stock Market Performance - The average increase of new stocks listed since 2024 is approximately 3.0%, with about 82.9% of new stocks showing positive returns[1] - The average increase for new stocks on the North Exchange is 5.5%, with around 96.2% of new stocks experiencing gains[5] - The average issuance price-to-earnings ratio for new stocks last week was 24.2X, with a subscription success rate of 0.0267%[4] Group 2: Market Trends and Recommendations - The current market is in a transformation window, with significant policy clarity expected to gradually materialize, indicating a potential new active cycle[2] - Caution is advised due to ongoing external disturbances, including geopolitical tensions and tariff negotiations, which may lead to market fluctuations[2] - Focus should be on near-term new stocks that have undergone sufficient adjustment and offer relatively high cost-performance ratios, particularly those benefiting from hot themes or policy expectations[3] Group 3: Upcoming New Stocks - This week, five new stocks are set to complete subscriptions, including one from the Sci-Tech Innovation Board and two from the Growth Enterprise Market[7] - One stock, Guqi Down Material, is expected to start pricing inquiries, being a significant supplier of duck down and goose down materials[8]

IPO Review and Registration Progress - Ningbo Jianxin Superconducting Technology Co., Ltd. has received acceptance for its IPO application on the Sci-Tech Innovation Board, marking the third new acceptance this year [2] - The company reported revenues of 359 million yuan, 451 million yuan, and 425 million yuan for 2022 to 2024, with net profits of 34.63 million yuan, 48.73 million yuan, and 55.78 million yuan respectively [2] - The company plans to raise 865 million yuan through its IPO for projects including the production of superconducting magnets and working capital [3] - Lianchuan Biotechnology has also received acceptance for its IPO on the Beijing Stock Exchange, aiming to raise 300 million yuan for projects related to gene technology and working capital [4] - The company reported revenues of 234 million yuan, 287 million yuan, and 367 million yuan from 2022 to 2024, with net profits of 52.76 million yuan, 53.49 million yuan, and 60.06 million yuan respectively [4] - Dana Biotechnology submitted its IPO registration on the Beijing Stock Exchange, focusing on early rapid diagnostic technology for invasive fungal diseases [6] - Han Gao Group's IPO registration has been approved, with projected revenues of 2.857 billion yuan and net profits of 531 million yuan for 2024 [6] New Stock Subscription and Listing Dynamics - Three new stocks are scheduled for subscription this week, including Hanbang Technology, Weigao Blood Purification, and Taili Technology [8] - Hanbang Technology aims to raise 598 million yuan for the production of liquid chromatography equipment, with projected revenues of 691 million yuan and net profits of 79 million yuan for 2024 [8] - Weigao Blood Purification plans to raise 1.351 billion yuan for smart production and other projects, with sales expenses exceeding 600 million yuan from 2022 to 2024 [9] - Taili Technology focuses on new materials and plans to raise 542 million yuan for production and logistics center construction, with projected revenues of 1.02 billion yuan and net profits of 88 million yuan for 2024 [9] Upcoming Listings - Tian Gong Co., Ltd. is set to be listed on the Beijing Stock Exchange on May 13, with projected revenues of 383 million yuan, 1.035 billion yuan, and 801 million yuan from 2022 to 2024 [11] - The company plans to raise 360 million yuan for the construction of high-end titanium and titanium alloy production lines [11] Policy and Regulatory Trends - The China Securities Regulatory Commission (CSRC) plans to introduce policies to deepen reforms in the Sci-Tech Innovation Board and the Growth Enterprise Market, enhancing the system's inclusiveness and adaptability [12]

IPO Dynamics - No companies are scheduled for IPO meetings in the A-share market [1] - No new stocks are listed this week in the A-share market [2] New Stock Subscription - Three new stocks are available for subscription this week, with no new stock subscriptions scheduled for next week [3] - Hanbang Technology (688755) is set to be subscribed on May 7, while Taili Technology (301595) and Weigao Blood Purification (603014) will be subscribed on May 8 [3] Hong Kong Stock Market - Several companies have passed the hearing for listing on the Hong Kong Stock Exchange, including Heng Rui Pharmaceutical, CATL, and Ji Hong Technology [4] - On May 8, Hong Kong's stock market welcomed the listing of "Hushang Ayi," which raised approximately HKD 195 million by issuing 241,130 shares at HKD 113.12 per share [5] - The founders of Hushang Ayi have a combined net worth of USD 1.1 billion, holding approximately 78.78% of the company's shares post-IPO [5] Upcoming Listings - Green Tea Group is expected to list on May 16, with a share price of HKD 7.19 and a total of 168 million shares being offered [6][7] - The company has secured eight cornerstone investors, with a total investment of approximately USD 87.33 million [7] Company Developments - Xiaopeng Motors is considering an IPO for its flying car subsidiary, Xiaopeng Huitian, with potential listings in Hong Kong or the U.S. [8] - Xiaopeng Huitian has received a significant loan of CNY 1.26 billion from a consortium of banks to support its manufacturing base [8] Regulatory Updates - The Hong Kong Stock Exchange has launched a "Tech Company Fast Track" to facilitate the listing of specialized technology and biotech companies, allowing for confidential submission of applications [9] - This initiative aims to support early-stage companies in understanding listing rules and preparing for the IPO process [9]

（文章来源：证券时报网） 灿芯股 科创板新股申购中签率情况 | 简称 | 申购代 | 发行日期 | 发行 | 发行总量（万 | 网上发行量（万 | 网上发行最终中签率 | | --- | --- | --- | --- | --- | --- | --- | | | 码 | | 价 | 股） | 股） | （%） | | 汉邦科 技 | 787755 | 2025.05.07 | 22.77 | 2200.00 | 704.00 | 0.03001029 | | 胜科纳 米 | 787757 | 2025.03.14 | 9.08 | 4033.11 | 1036.05 | 0.03181202 | | 海博思 创 | 787411 | 2025.01.16 | 19.38 | 4443.25 | 1512.60 | 0.0329001 | | 兴福电 子 | 787545 | 2025.01.13 | 11.68 | 10000.00 | 2828.85 | 0.03877818 | | 思看科 技 | 787583 | 2025.01.06 | 33.46 | 1700.00 | 544.00 | 0.0 ...

Core Insights - The total amount raised by companies on the Sci-Tech Innovation Board (STAR Market) this year has reached 3.465 billion yuan, with an average fundraising of 693 million yuan per company [1][2] - The company with the highest fundraising amount is Xingfu Electronics, which raised 1.168 billion yuan, primarily for cash management and various electronic chemical projects [1] - The average initial offering price for the issued stocks is 19.27 yuan, with the highest being 33.46 yuan for Sikan Technology [1][2] Fundraising Overview - A total of 5 companies have issued new shares on the STAR Market this year, with 1 company raising over 1 billion yuan, 3 companies raising between 500 million and 1 billion yuan, and 1 company raising less than 500 million yuan [1] - The companies that raised significant amounts include Xingfu Electronics (1.168 billion yuan), Haibo Sichuang (861 million yuan), Sikan Technology (569 million yuan), Hanbang Technology (501 million yuan), and Shengke Nano (366 million yuan) [1] Pricing and Valuation - The average issuance price for the stocks is 19.27 yuan, with Sikan Technology having the highest issuance price at 33.46 yuan, followed by Hanbang Technology at 22.77 yuan and Haibo Sichuang at 19.38 yuan [1] - The issuance price for Shengke Nano and Xingfu Electronics is lower, at 9.08 yuan and 11.68 yuan respectively [1] Earnings Ratios - The issuance price-to-earnings (P/E) ratio for the issued companies ranges from 6.14 to 42.64, with an average of 27.72 and a median of 26.35 [2] - Shengke Nano has the highest P/E ratio at 42.64, while several companies including Sikan Technology, Haibo Sichuang, and Hanbang Technology have P/E ratios below the industry average [2] Geographic Distribution - The newly issued companies are primarily located in Jiangsu, Zhejiang, and Hubei provinces, with Hubei leading in fundraising amounts [2] - The top fundraising regions are Hubei (1.168 billion yuan), Jiangsu (867 million yuan), and Beijing (861 million yuan) [2]

Company Overview - Hanbang Technology has entered the IPO subscription phase on May 7, with a subscription code of 787755 and a price of 22.77 yuan per share. The company specializes in providing separation and purification equipment, consumables, and technical services in the pharmaceutical and life sciences sectors [1] Market Position - In 2023, the total market size for liquid chromatography equipment in China exceeded 2.7 billion yuan, with Hanbang Technology ranking second in the production-grade liquid chromatography separation equipment market, holding a market share of approximately 12.7%. For production-grade equipment alone, Hanbang's market share reached 39.2%, making it the market leader [1] - The market for production-grade macromolecular chromatography systems in China was about 2.5 billion yuan in 2023, where Hanbang Technology held a market share of approximately 8.8%, ranking third [1] Industry Context - The domestic high-end pharmaceutical equipment sector has developed relatively late, with a long-standing reliance on imports for core production equipment such as chromatography systems. This reliance has led to high procurement and maintenance costs, impacting the upgrade and development of the pharmaceutical industry [2] - With ongoing reforms in the pharmaceutical industry, policies such as "medical insurance cost control," "consistency evaluation of generic drugs," and "volume-based procurement" have raised the cost control and quality standards for pharmaceutical companies. This has increased the demand for high-quality domestic equipment [2] Customer Relations and Sales Strategy - Hanbang Technology's customer base is primarily domestic, allowing for closer proximity to clients compared to foreign competitors. This geographical advantage enables the company to provide comprehensive and rapid technical support and solutions [2] - The company has established a robust customer service team to understand client needs in real-time and develop corresponding solutions to ensure the swift establishment and stable operation of client production lines. Hanbang maintains close cooperation with clients, participating in the development of client solutions and responding promptly to feedback [2] Financial Performance - In 2024, the company's projected revenue is 691 million yuan, up from 619 million yuan in 2023 and 481 million yuan in 2022, reflecting a compound annual growth rate (CAGR) of 19.75%. The net profit attributable to the parent company, excluding non-recurring gains and losses, was 76.05 million yuan in 2023, compared to 50.69 million yuan in 2022 and 38.55 million yuan in 2021, with a CAGR of 40.46% [3] - For the first quarter of 2025, the company expects a year-on-year revenue growth of 5.13% to 17.53%, with net profit growth of 50.11% to 158.41% after excluding non-recurring gains and losses [3]

| 新股发行及今日交易提示 | 2025/5/7 | 星期三 | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 2025/5/7 | 新股发行 | 证券代码 | 证券简称 | 发行价格 | | | | | 787755 | 汉邦科技 | 22.77 | 2025/5/7 | 内地市场权益提示 | | | | | 类别 | 证券代码 | 证券简称 | 权益日期 | 最新公告链接 | https://www.cninfo.com.cn/new/disclosure/detail?stockCode=600777&announcementId=122337 | 要约申报期1：2025年4月8日至2025年5月7日 | | | 5830&orgId=gssh0600777&announcementTime=2025 | -04-29 | 要约收购 | 600777 | ST新潮 | https://www.cninfo.com.cn/new/disclosure/detail?stockCode=600777&announcementId= ...

Important Announcements - A new stock, Hanbang Technology, is available for subscription with a price of 22.77 yuan per share and a subscription limit of 0.50 million shares [1] - The Chinese government will hold a press conference to discuss a comprehensive financial policy aimed at stabilizing the market and expectations [1] International Relations - Chinese Vice Premier He Lifeng will visit Switzerland from May 9 to 12 for talks with U.S. Treasury Secretary Janet Yellen as part of the China-U.S. economic and trade discussions [1] Economic Indicators - China's GDP grew by 5.4% year-on-year in the first quarter, with a target of around 5% growth for 2025 [2] - The contribution of China to global economic growth has remained around 30% in recent years [2] Market Developments - The Hong Kong Securities and Futures Commission and the Hong Kong Stock Exchange have launched a "Tech Company Fast Track" to facilitate the listing of technology and biotech companies [3] - The State Post Bureau reported that during the May Day holiday, the express delivery industry handled over 4.8 billion packages, a year-on-year increase of over 20% [3] Company News - Daying Electronics is currently generating revenue from its humanoid robot business [6] - Zhaofeng Co. has not yet started any robot-related business, with its planetary roller screw research and sample testing in the early stages [6] - Huazhi Digital Media's film "Dumpling Queen" has grossed approximately 218 million yuan as of May 5 [6] - Aoheng Electric has received a contract from a leading new energy vehicle brand [6] - A contract worth 297 million yuan has been signed by Aopu Optoelectronics for the development of an optical system [6] - Huamao Technology and Yunda Co. plan to increase their shareholdings by 100 to 200 million yuan and 200 to 300 million yuan, respectively [6] Industry Insights - The automotive industry is expected to continue its growth, driven by trends in intelligent driving and international expansion, with key beneficiaries including new energy vehicles and core supply chain companies [14] - The A-share market is anticipated to shift towards small-cap growth stocks as seasonal effects diminish and external liquidity conditions improve [14]